Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Research Use Only Not for human consumption or medical use
doi: 10.1186/s40345-016-00544
By targeting GLP-1 receptors in the brain and pancreas, GLP-1 agonists exert their effects on weight loss and glycemic control
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes
Patients should discuss all medications and supplements with their healthcare provider
US$ 25.24
US$ 28.86
US$ 21.98
US$ 26.25
